The dataset contained transcriptomes from 22,951 single cells from different disease stages (1–8 months, control, and 5XFAD) as well as Trem2+/+ and Trem2−/− AD and control mice (Trem2 is a key receptor that modulates immune response). This evidence concerns the gene TREM2 and Alzheimer disease.